TETRALYSAL

This brand name is authorized in Brazil, Ecuador, Finland, France, Hong Kong, Ireland, Malta, New Zealand, Poland, Tunisia, United Kingdom, South Africa

Active ingredients

The drug TETRALYSAL contains one active pharmaceutical ingredient (API):

1 Lymecycline UNII 7D6EM3S13P - LYMECYCLINE

Tetracyclines provide bacteriostatic action at the available plasma and tissue concentrations and are effective against intracellular and extracellular organisms. Their mechanism of action is based on an inhibition of ribosomal protein synthesis.

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TETRALYSAL Hard capsule	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01AA04	Lymecycline	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01A Tetracyclines → J01AA Tetracyclines
Discover more medicines within J01AA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 510101702115311, 510101703111318, 510101704118413
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 24.399-04-02, 25.618-04-04
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 002422, 012831, 157016
Country: FR	Base de données publique des médicaments	Identifier(s): 60061171, 60891060
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 21562, 73359
Country: HK	Department of Health Drug Office	Identifier(s): 06231
Country: IE	Health Products Regulatory Authority	Identifier(s): 13214, 78305, 78308, 78357
Country: MT	Medicines Authority	Identifier(s): AA117/00703, AA908/25101
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 253
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100110665, 100174872, 100240020, 100330987, 100335571, 100462892
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 7393101
Country: ZA	Health Products Regulatory Authority	Identifier(s): E/20.1.1/67